Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and In Vivo bioavailability-Reference-Cited by-同舟云学术

Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and In Vivo bioavailability

Published:2012-10 Issue:10 Volume:101 Page:3763-3778
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Miller Maria A.,Khan Tarik A.,Kaczorowski Kevin J.,Wilson Brian K.,Dinin Aileen K.,Borwankar Ameya U.,Rodrigues Miguel A.,Truskett Thomas M.,Johnston Keith P.,Maynard Jennifer A.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference74 articles.

1. Monoclonal antibody successes in the clinic;Reichert;Nat Biotechnol,2005

2. Development trends for human monoclonal antibody therapeutics;Nelson;Nat Rev Drug Disc,2010

3. Measuring and increasing protein solubility;Trevino;J Pharm Sci,2008

4. Design of therapeutic proteins with enhanced stability;Chennamsetty;Proc Natl Acad Sci U S A,2009

5. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity;Maynard;Nat Biotechnol,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume;mAbs;2023-11-27

2. High concentration formulation developability approaches and considerations;mAbs;2023-05-16

3. Formulation and characterization of insulin nanoclusters for a controlled release;International Journal of Biological Macromolecules;2023-04

4. Biopharmaceutical nanoclusters: Towards the self-delivery of protein and peptide therapeutics;Journal of Controlled Release;2022-07

5. Polymer-templated supramolecular co-assemblies of proteins and metal oxide clusters as versatile platform for chemo-enzymatic catalysis;Journal of Colloid and Interface Science;2021-07